GMO Pepabo, Inc. (JP:3633) has released an update.
GMO Pepabo, Inc. reported consolidated net sales of 8,105 million yen for the first nine months of 2024, with a slight decrease from the previous year, but saw a positive shift in profitability with a profit attributable to owners of 551 million yen compared to a loss in 2023. The company’s equity ratio improved to 21.5% as of September 2024, indicating a stronger financial position. Despite zero dividends so far, a forecasted end-year dividend of 53 yen per share reflects optimism for future growth.
For further insights into JP:3633 stock, check out TipRanks’ Stock Analysis page.